BioLamina Email Format
Biotechnology ResearchStockholm, Sweden51-200 Employees
BioLamina is a Swedish biotechnology company grounded in matrix biology and cell culture research. It develops tools to enable efficient and reliable growth of pluripotent stem cells and other primary cells in the lab. The aim is to ease the path toward safe and effective cell therapies and to improve cell assays and disease models used in drug discovery and development. The Biolaminin substrates it develops have been demonstrated in numerous publications, reflecting its role in supporting the stem cell community from basic research to clinical studies. Based in Sundbyberg, in the Stockholm region of Sweden, BioLamina operates as a mid-sized company within the biotechnology research sector, serving scientists focused on stem cell research and related drug development. In 2026, BioLamina announced a strategic collaboration with Cytochroma to advance iPSC-derived cells for drug discovery and disease modelling.